期刊
AMERICAN JOURNAL OF NEURORADIOLOGY
卷 31, 期 7, 页码 1178-1180出版社
AMER SOC NEURORADIOLOGY
DOI: 10.3174/ajnr.A2142
关键词
-
Rituximab is a monoclonal antibody that was first approved by the FDA as an antineoplastic agent designed to treat B-cell malignancies. This article will review the mechanism of action and clinical role of this anti-B-cell agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
